stockrow
Friday 6 November 2026
Export RNLXY’s income statement to Excel — free account
Renalytix plc - Sponsored ADR
RNLXY Healthcare Health Information Services
Renalytix plc - Sponsored ADR’s revenue for fiscal 2025 (year ended June 2025) was $3.0 million, up 30.4% from fiscal 2024.
3.70
0.09
−2.37%
Follow RNLXY
Alert me
| Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Dec '19 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 2 | 2 | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
4.14 | 5.91 | 35.53 | 30.05 | 689.07 | — | — | — | — | — |
Altman Z-Score |
(45.27) | (38.03) | (9.10) | (3.61) | 91.05 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(106.67) | (89.52) | (25.63) | (9.81) | 9.18 | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Beneish M-Score |
(5.13) | (11.47) | (4.36) | (2.79) | — | — | — | — | — | — |
P/Operating CF |
(1.51) | (1.81) | (14.00) | (6.30) | (216.40) | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 17.35 | 2.92 | 15.44 | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 17.35 | 2.92 | 15.44 | — | — | — | — | — |
EV/Sales |
3.51 | 5.43 | 30.49 | 18.72 | 648.40 | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
(0.37) | (0.42) | (3.04) | (1.21) | (36.55) | — | — | — | — | — |
EV/FCF |
(0.36) | (0.41) | (2.99) | (1.19) | (34.69) | — | — | — | — | — |
Quick Ratio |
0.92 | 0.52 | 1.58 | 3.59 | 9.31 | 4.34 | — | 8.00 | 0.19 | — |
Current Ratio |
1.21 | 0.58 | 1.67 | 3.80 | 9.46 | 4.51 | — | 8.20 | 0.20 | — |
Net Debt/EBITDA |
(0.26) | 0.04 | 0.41 | 0.64 | 2.06 | 1.38 | — | 0.22 | (0.87) | — |
Debt/Assets |
136.07% | 53.94% | 24.57% | 15.34% | 0.00% | 0.65% | 0.00% | 0.00% | 492.28% | 0.00% |
Debt/Equity |
(1.19) | (0.55) | 1.08 | 0.25 | 0.00 | 0.01 | — | 0.00 | (1.26) | — |
Asset Turnover |
0.43 | 0.12 | 0.08 | 0.05 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.88 | 0.89 | 0.75 | 1.01 | 0.82 | 0.97 | — | 0.15 | 1.01 | — |
Capex/Depreciation |
— | 0.00 | 0.00 | (1.35) | (5.40) | (17.59) | — | (9.97) | — | — |
| 255.00% | 3,291.29% | (242.76%) | (88.72%) | (79.49%) | (80.48%) | — | (1,031.32%) | (10.02%) | — | |
| (289.94%) | (173.34%) | (113.04%) | (70.39%) | (69.83%) | (64.38%) | 0.00% | (864.28%) | (921.96%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (314.98%) | (363.82%) | — | 0.00% | 0.00% | — |
Return on Tangible Assets |
(1,700.00%) | 697.00% | (387.39%) | (131.82%) | (55.81%) | (74.54%) | — | (494.69%) | 117.51% | — |
Average Days of Receivables |
73.00 | 111.09 | 83.23 | 110.73 | 145.66 | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 403.91% | 420.16% | 493.20% | 673.37% | 0.00% | — | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
613.33% | 1,334.78% | 842.26% | 1,330.77% | 1,574.71% | 0.00% | — | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
106.67% | 47.83% | 86.16% | 155.59% | 178.60% | 0.00% | — | 0.00% | — | — |
Graham Net Nets |
(0.17) | (0.66) | 0.03 | 0.28 | 0.05 | — | — | — | — | — |
Graham Number |
— | 43.60 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
(371.87%) | (324.37%) | (37.72%) | (50.73%) | (3.20%) | — | — | — | — | — |
Free Cash Flow Yield |
(235.86%) | (222.12%) | (28.74%) | (52.20%) | (2.71%) | — | — | — | — | — |
Revenue per Share |
0.51 | 1.06 | 2.05 | 2.04 | 1.04 | 0.00 | — | 0.00 | 0.00 | — |
Operating CF per Share |
(3.07) | (13.75) | (20.58) | (31.52) | (19.86) | (8.06) | — | (7.23) | (0.01) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.45) | (1.06) | (1.04) | — | (0.36) | 0.00 | — |
Free Cash Flow per Share |
(3.07) | (13.76) | (20.58) | (31.97) | (20.93) | (9.10) | — | (7.60) | (0.01) | — |
Cash per Share |
0.65 | 2.49 | 14.90 | 28.36 | 45.55 | 12.08 | — | 10.80 | 0.00 | — |
Shareholders Equity per Share |
(1.20) | (3.62) | 4.21 | 21.00 | 49.98 | 13.47 | — | 10.05 | (0.01) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — |
Book value per Share |
(1.20) | (3.62) | 4.21 | 21.00 | 49.98 | 13.47 | — | 10.05 | (0.01) | — |
Free Cash Flow |
(17.90) | (29.80) | (34.08) | (46.59) | (29.92) | (10.75) | — | (6.46) | (0.41) | — |
Working Capital |
1.00 | (5.00) | 10.75 | 32.98 | 59.73 | 11.55 | — | 8.27 | (0.35) | — |
Capital Expenditures |
— | 0.00 | — | (0.66) | (1.52) | (1.23) | — | (0.31) | — | — |
Net Current Asset Value |
(7.30) | (9.03) | 3.22 | 25.30 | 59.68 | 9.87 | — | 8.27 | (0.35) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.22 | 1.02 | 0.00 | — | 0.00 | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 12.50 | 0.49 | 0.36 | 0.11 | 0.04 | — | 0.11 | — | — |
Cash ROIC |
(350.98%) | (1,614.52%) | (87.01%) | (58.51%) | (21.91%) | (35.46%) | — | (36.43%) | (241.98%) | — |
Accounts Receivable Turnover |
4.62 | 3.12 | 4.06 | 3.97 | 4.86 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.29 | 0.40 | 0.99 | 0.99 | 0.43 | 0.06 | — | 0.02 | — | — |
Inventory Turnover |
7.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — |
Average Days of Payables |
973.33 | 1,320.95 | 399.42 | 428.21 | 750.42 | 11,152.24 | — | 3,808.62 | — | — |
Days of Inventory on Hand |
40.56 | 52.14 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — |
Average Receivables |
0.65 | 0.74 | 0.84 | 0.75 | 0.31 | 0.35 | — | — | — | — |
Average Payables |
6.20 | 5.27 | 2.70 | 2.11 | 1.99 | 1.27 | — | 1.27 | — | — |
Average Inventory |
0.25 | — | — | — | — | — | — | — | — | — |
Average Assets |
7.04 | 19.30 | 40.35 | 64.32 | 49.73 | 15.29 | 4.85 | 4.89 | 0.04 | — |
Average Common Equity |
(8.00) | (1.02) | 18.79 | 51.03 | 43.69 | 12.23 | — | 4.10 | 4.08 | — |
Columns are period end dates · fundamentals updated 26 Oct 2026